Akademik Veri Yönetim Sistemi
TIBBI ONKOLOJI - GERIATRIK ONKOLOJI, ss.62-69, 2020 (SCI-Expanded)
The world population is increasing. In addition to the increasing population, the proportion of the elderly population is gradually increasing. Cancer, especially lung cancer, which is our subject, is basically a disease of advanced age. Physiological and some pathological changes caused by aging affect the treatment decision, and the path to be followed may differ according to young people. Systemic treatment and management of lung cancer in the geriatric patient population that we encounter more and more frequently in our practice every day and will be more frequent in the future, has special features. Age should not be a stand-alone criterion in the choice of treatment, just because of age, the patient should not receive less than the care he should receive. Although the number of studies conducted in the geriatric age group is small, subgroup analyzes show that the treatments can give similar results in elderly patients.